Press Releases
June 1, 2026

AIM Expands Life Sciences Supply Chain Capabilities and Hires New Partner, Thomas Ebel

Rotterdam, The Netherlands, June 1, 2026 – AIM today announced the appointment of veteran pharma supply chain expert Thomas Ebel as Partner, effective June 15. Mr. Ebel brings more than 25 years of supply chain consulting experience at leading firms including CAMELOT, McKinsey, and Accenture, and will anchor a broader initiative to expand AIM’s end-to-end supply chain capabilities.

According to Richard de Bakker, Statutory Director and Founder at AIM, the firm is significantly expanding its capabilities around “end-to-end” supply chain needs. “AIM is well known as a leader in supply chain development for launch, as well as optimization of existing supply chains — supporting clients in getting their finished products to patients,” said Mr. de Bakker. “We are now adding new capabilities in supply chain diagnostics and strategy, end-to-end planning optimization, supply reliability, and working capital optimization, among others. Combined with AIM’s established supply chain expertise, this expanded offering gives clients true ‘end-to-end’ support, from source to patient.”

Mr. de Bakker added, “What Thomas brings in end-to-end supply chain strategy and optimization complements what AIM already does exceptionally well. We’re delighted to have him on board.” Mr. Ebel will play a key role in expanding AIM’s capabilities and is expected to grow the team by recruiting additional specialists in the months ahead.

“I was attracted to AIM by a rare combination,” said Mr. Ebel. “Genuine deep expertise in life science supply chain and distribution, a hands-on pragmatic approach, and a team of consultants who have actually done the work. The track record speaks for itself, and I’m excited to get started. In these times, life science companies need to move from defense to offense and build stronger supply chains that are both integrated with the business and adaptable to change. This is where we will focus.”

About AIM

AIM (www.aimconnection.eu), a Blue Matter company, is the trusted supply chain specialist for life science companies. From its offices in the Netherlands, AIM provides end-to-end supply chain services and support across the globe. It helps a broad range of pharmaceutical and biotech companies strategically design, build, implement, and maintain their operational and supply chain infrastructures. AIM supports companies at every stage, from emerging clinical-stage innovators preparing for their first product launch to large established global organizations optimizing complex supply chains.

###

Contact

Craig Dunkley
cdunkley@bluematterconsulting.com
+1(919) 539-0658

Press Releases
May 28, 2026

AIM Recognized in Consultancy UK’s Top Consulting Firms 2026 Rankings

AIM has been recognized again in Consultancy.uk’s Top Consulting Firms 2026 Ranking, achieving Gold Rankings in both Supply Chain and Pharma & Life Sciences – standing out among 500 firms assessed.

The rankings are based on input from clients and consultants across the industry, alongside an evaluation of firm reputation, projects, industry recognition and thought leadership.

Click here to read more about the rankings.

Press Releases
December 8, 2025

AIM Ranks in Consultancy.nl’s Top Consulting Firms 2025 Survey

AIM has been recognized again in Consultancy.nl’s Top Consulting Firms 2025 Ranking, achieving a Platinum Ranking in Pharma & Life Sciences and Gold Ranking in Supply Chain Management – standing out among 500 firms assessed.

The ranking is based on a survey among customers & consultants and a capabilities assessment. The survey was completed this year by ~650 customers (they gave 1,400 customer reviews in the various fields and sectors) and by ~850 consultants (over 4,300 reviews in the areas).

Click here to read more about the rankings.

Press Releases
June 17, 2025

AIM Receives Gold Rankings in Consultancy UK’s Top Consulting Firms 2025

AIM has been recognized again in Consultancy.uk’s Top Consulting Firms 2025 Ranking, achieving Gold Rankings in both Supply Chain and Pharma & Life Sciences – standing out among 500 firms assessed.

The rankings are based on input from clients and consultants across the industry, alongside an evaluation of firm reputation, projects, industry recognition and thought leadership.

Click here to read more about the rankings.

Press Releases
January 7, 2025

AIM recognized in Consultancy.nl’s Top Consulting Firm 2024 Rankings

AIM has been recognized in the Consultancy.nl Top Consulting Firms 2024 Rankings.

Among 500 firms assessed, AIM achieved the following rankings:
– Gold in Pharma & Life Sciences
– Silver in Supply Chain Management

Consulting firms ranked on the list are known as the most trusted, expert, and influential players in their field. They help businesses, governments, nonprofits, and other clients solve their biggest challenges and capitalize on their most significant opportunities.

The ranking was compiled through a thorough process based on a capacity assessment (thousands of data points across five dimensions) and feedback from clients (over 1,100 reviews) and consultants (over 4,200 company ratings across various areas of expertise). The data was verified and enriched with Consultancy.org’s extensive global database.

The AIM team extends it’s deepest gratitude to our customers and partners for their continued trust and to our talented team that make this possible.

Click here to view the full rankings.

Press Releases
January 18, 2021

AIM Announces Its Acquisition by Blue Matter, a Leading Strategic Consultancy Focused on the Life Sciences

By AIM

Voorburg, the Netherlands, January 18, 2021 – AIM is pleased to announce that it has been acquired by Blue Matter, a leading strategic consulting firm specializing in the life science industry. AIM will continue to operate under its own name and maintain its identity as a leading specialist in life science supply chains. The new arrangement is expected to provide strategic and mutual benefits to both AIM and Blue Matter.

AIM will provide a strategic complement to Blue Matter’s offerings and enhance its Pathfinder^SM suite of capabilities, which are designed to help biopharma companies enter European markets and succeed. According to George Schmidt, Blue Matter Managing Partner in London, “We typically lead strategy work, but clients often have specialized needs when it comes to establishing operations in Europe, such as building and running flawless supply chains. AIM directly addresses that need.”

AIM’s founder, Richard de Bakker added, “Blue Matter and AIM have a long, positive relationship. We often serve the same clients, with needs that intersect the capabilities of both firms. By joining forces, we can boost the value of each firm while providing enhanced services to clients. It will also provide additional opportunities for AIM’s consulting team.”

Blue Matter’s proximity to emerging companies in the US will allow AIM to engage with them earlier, as they decide whether and how to enter Europe. AIM will continue providing consultancy and interim management services to pharmaceutical companies in Europe and elsewhere.

The acquisition was finalized on December 31, 2020.

About AIM

AIM (www.aimconnection.eu) is a specialized firm providing supply chain consultancy and interim management services to the life science industry in Europe and beyond. From its offices in the Netherlands, the firm serves a broad and international range of pharmaceutical, biotech, and life science companies. AIM helps its clients strategically design, implement, manage, and maintain their operational and supply chain infrastructures.

Contact:

Craig Dunkley
cdunkley@bluematterconsulting.com
(919) 539-0658